A detailed analysis of the Global Anti-Infective Agents Market 2023 is provided, including global, regional, and country-level market sizes, segmentation market growth, market share, competitive landscape, sales analysis, impact of domestic and global Anti-Infective Agents Market players, value chain optimization, trade regulations, recent developments, strategic market growth analyses, product launches, expanding the area market, and technological advances.

The global anti-infective agents market size was USD 116.91 billion in 2022 and is expected to reach USD 197.52 billion in 2032 growing at a CAGR of 6% during the forecast period. Rising prevalence of infectious diseases across the globe is one of the key factors driving market revenue growth.

Request a sample report of Anti-Infective Agents Market @ https://www.reportsanddata.com/download-free-sample/6214

Market Overview:

In the pharmaceutical and healthcare sectors, there is rapid change. As cell and gene therapies become increasingly available, patients are finding appropriate treatments for previously incurable diseases. Machine learning and artificial intelligence (AI) technologies are making it possible for more inventive, faster, and cheaper therapy development to take place. By utilizing data-driven projects, manufacturing, the supply chain, and the entire healthcare ecosystem can benefit. It is clear that consumer attitudes and behaviors are shifting, ranging from a greater use of technology and data sharing to a willingness to use tools to make prescriptions and treatment decisions. Pharma and healthcare markets are expected to grow in the next few years as a result of such factors.

Key Players covered in this report are

  • Pfizer Inc.
  • GlaxoSmithKline plc.
  • Merck & Co. Inc.
  • AstraZeneca
  • Novartis International AG
  • Bayer AG
  • Roche Holding AG
  • Johnson & Johnson
  • Sanofi S.A.
  • Eli Lilly and Company

Based on Drug Class market is segmented into:

  • Antibacterial
  • Antiviral
  • Antifungal
  • Antiparasitic

Based on Indication Outlook market is segmented into:

  • Respiratory
  • Gastrointestinal
  • CNS
  • Genitourinary
  • Others

Read the full report @ https://www.reportsanddata.com/report-detail/anti-infective-agents-market

Based on Region market is segmented into:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

Strategic Development:

  • On 28 April 2021, Pfizer acquired Amplyx Pharmaceuticals, which a biopharmaceutical business with a focus on creating cures for fatal infections. The acquisition was made in order to increase Pfizer's selection of anti-infective medications and enhance patient outcomes for fungus infections.
  • On 13 June 2020, AstraZeneca declared that it had reached a deal with the European Commission under which it will provide up to 400 million doses of its COVID-19 vaccine, which had been created in association with the University of Oxford. The goal of the agreement was to make sure that all of the European Union's member nations could obtain the vaccination.
  • On 6 April 2020, GlaxoSmithKline plc partnered with Vir Biotechnology, Inc. to create and market COVID-19 therapies. The cooperation aimed to create COVID-19 treatments that worked and enhance patient outcomes.
  • On 28 October 2020, Novartis International AG declared that it has partnered with Molecular Partners AG to create and market COVID-19 therapies. The cooperation aimed to create novel COVID-19 treatments that would benefit patients and enhance outcomes.

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/6214

We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

(Head of Business Development)

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: [email protected]

Blogs | Press Release | Industry News | Our competencies

Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports

Browse More Latest Reports @ https://www.reportsanddata.com/report